Akanda Corp. Common Shares
AKANStock
$9.57−89.87%52W
Market Cap$7.86M
P/E—
Div yield—
Beta14.24
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-28.88%
Price vs S&P 500 (4W)-46.19%
VGM Score37.80
Market Capitalization$7.86M
Industry Peers — Pharmaceutical Preparations(21)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AKANAkanda Corp. Common Shares | C | F | C | $9.57 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $44.10 |
| RGCRegencell Bioscience Holdings Limited Ordinary Shares | — | — | F | $4.78 |
| TRLVTrulieve Cannabis Corp. | B | C | A | $8.41 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.75 |
| GLASGlass House Brands Inc. | C | C | B | $10.34 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.35 |
| USNAUSANA Health Sciences Inc | B | D | C | $22.65 |
| CGCCanopy Growth Corporation Common Shares | B | C | C | $0.93 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.40 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.29 |
About
Akanda Corp is a vertically integrated cannabis company that cultivates, manufactures, and distributes medical cannabis products in the United Kingdom. The company generates substantially all of its revenue through its Distribution segment, which supplies medical cannabis oils and cannabis flower products. By controlling cultivation, manufacturing, and distribution, Akanda maintains an integrated supply chain for its medical cannabis business.